Jeil Pharmaceutical Co.,Ltd (KRX:271980)

Market Cap	225.13B
Revenue (ttm)	621.98B
Net Income (ttm)	19.64B
Shares Out	14.57M
EPS (ttm)	1,347.46
PE Ratio	11.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,788
Average Volume	35,482
Open	16,100
Previous Close	15,700
Day's Range	15,060 - 16,100
52-Week Range	10,120 - 17,800
Beta	0.54
RSI	59.86
Earnings Date	Nov 14, 2025

About KRX:271980

Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 947
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 271980